Category,Field_Name,Chinese_Name,Data_Type,Unit,Valid_Range,LOINC_Code,Required,Description,Clinical_Significance
Basic_Info,patient_id,患者ID,string,,,,,Y,唯一标识,患者追踪
Basic_Info,diagnosis_date,诊断日期,date,,,,,Y,确诊时间,疾病起点
Basic_Info,age,年龄,integer,years,18-120,,,Y,患者年龄,预后因素
Reproductive_History,parity,产次,integer,,0-20,,,N,生产次数,未产妇风险增加
Reproductive_History,brca_family_history,乳腺卵巢癌家族史,categorical,,None,Breast_Cancer,Ovarian_Cancer,Both,,,N,无/乳腺癌/卵巢癌/两者,遗传风险
Reproductive_History,hrt_use,激素替代治疗,categorical,,Never,Current,Former,,,N,从未/正在/既往,危险因素
Histology,histologic_type,组织学类型,categorical,,High_Grade_Serous,Low_Grade_Serous,Endometrioid,Clear_Cell,Mucinous,Other,,,Y,高级别浆液性/低级别浆液性/子宫内膜样/透明细胞/黏液性/其他,70%为高级别浆液性
Histology,differentiation,分化程度,categorical,,Well,Moderate,Poor,,,N,高/中/低,预后因素
Tumor_Location,laterality,单双侧,categorical,,Unilateral,Bilateral,,,Y,单侧/双侧,双侧提示晚期
Tumor_Location,primary_site,原发部位,categorical,,Ovary,Fallopian_Tube,Primary_Peritoneal,,,Y,卵巢/输卵管/原发腹膜,同等治疗
FIGO_Staging,figo_stage,FIGO分期,categorical,,IA,IB,IC1,IC2,IC3,IIA,IIB,IIIA1,IIIA2,IIIB,IIIC,IVA,IVB,,,Y,国际妇产科联盟分期,IA:单侧包膜完整/IB:双侧包膜完整/IC1:术中破裂/IC2:术前破裂或表面肿瘤/IC3:腹水或腹腔冲洗液阳性/II:盆腔扩散/III:腹腔扩散或腹膜后淋巴结/IV:远处转移
TNM_Staging,tnm_stage,TNM分期,categorical,,IA,IB,IC,IIA,IIB,IIIA1,IIIA2,IIIB,IIIC,IVA,IVB,,,N,AJCC 8th,对应FIGO
Performance,ecog_ps,ECOG体能状态,integer,,0-5,89247-1,,Y,0-5分,治疗耐受性
Labs,ca125,糖类抗原125,decimal,U/mL,0-10000,10334-1,,Y,CA125,诊断监测标志物
Labs,he4,人附睾蛋白4,decimal,pmol/L,0-1000,83080-0,,N,HE4,辅助诊断
Labs,roma_index,ROMA指数,decimal,,0-100,,,N,卵巢恶性肿瘤风险算法,CA125+HE4计算
Labs,cea,癌胚抗原,decimal,ng/mL,0-1000,2039-6,,N,CEA,黏液性卵巢癌
Labs,afp,甲胎蛋白,decimal,ng/mL,0-1000,1834-1,,N,AFP,生殖细胞肿瘤
Labs,ldh,乳酸脱氢酶,decimal,U/L,0-2000,2532-0,,N,LDH,生殖细胞肿瘤
Imaging,ct_findings,CT表现,string,,,,,Y,卵巢肿块/腹水/种植,影像学特征
Imaging,mri_findings,MRI表现,string,,,,,N,软组织分辨率,附件肿块评估
Imaging,ascites,腹水,categorical,,None,Minimal,Moderate,Massive,,,Y,无/少量/中量/大量,疾病负荷
Imaging,omental_involvement,网膜受累,categorical,,None,Miliary,Cake,,,N,无/粟粒状/网膜饼,上腹部疾病
Diagnosis,preoperative_biopsy,术前活检,categorical,,Not_Done,Benign,Malignant,,,N,未做/良性/恶性,多数术中诊断
Treatment_Surgery,primary_debulking,初次肿瘤减灭术,categorical,,None,Optimal,Suboptimal,,,N,无/理想型/次理想型,理想型:残留<1cm
Treatment_Surgery,surgical_procedure,手术范围,string,,,,,N,TAH-BSO/网膜切除/淋巴结清扫,标准术式
Treatment_Surgery,residual_disease,残留病灶,categorical,,No_Gross_Residual,Less_Than_1cm,Greater_Than_1cm,,,N,无肉眼残留/小于1cm/大于1cm,预后关键因素
Treatment_Surgery,lymph_nodes_examined,淋巴结检查数,integer,,0-100,,,N,盆腔和腹主动脉旁,分期准确性
Treatment_Surgery,lymph_nodes_positive,阳性淋巴结数,integer,,0-100,,,N,转移淋巴结数,预后因素
Treatment_NACT,neoadjuvant_chemotherapy,新辅助化疗,categorical,,None,Carboplatin_Paclitaxel,,,N,无/卡铂+紫杉醇,晚期无法初次理想减瘤
Treatment_NACT,interval_debulking,间歇性肿瘤减灭术,categorical,,Not_Applicable,Optimal,Suboptimal,,,N,不适用/理想型/次理想型,NACT后手术
Treatment_Adjuvant,adjuvant_chemotherapy,辅助化疗,categorical,,None,Carboplatin_Paclitaxel,Dose_Dense,,,N,无/卡铂+紫杉醇/剂量密集,术后标准治疗
Treatment_Adjuvant,chemotherapy_cycles,化疗周期数,integer,,0-20,,,N,完成周期数,标准6周期
Treatment_Maintenance,maintenance_therapy,维持治疗,categorical,,None,Bevacizumab,Olaparib,Niraparib,Rucaparib,,,N,无/贝伐珠单抗/奥拉帕利/尼拉帕利/卢卡帕利,PARP抑制剂或抗血管生成
Treatment_Recurrent,platinum_sensitivity,铂类敏感性,categorical,,Sensitive,Resistant,Refractory,,,N,敏感型(TFI≥6月)/耐药型(TFI<6月)/难治型,复发治疗策略
Treatment_Recurrent,recurrence_treatment,复发治疗,categorical,,None,Platinum_Based,Non_Platinum,Secondary_Debulking,,,N,无/铂类为基础/非铂类/二次减瘤术,个体化治疗
Molecular,brca_mutation,BRCA突变,categorical,,Not_Tested,Negative,BRCA1,BRCA2,,,Y,未检测/阴性/BRCA1/BRCA2,PARP抑制剂适应证
Molecular,hrd_status,同源重组缺陷,categorical,,Not_Tested,HRD_Negative,HRD_Positive,,,N,未检测/阴性/阳性,PARP抑制剂疗效预测
Molecular,msi_status,微卫星不稳定性,categorical,,Not_Tested,MSS,MSI_H,,,N,未检测/稳定/高度不稳定,免疫治疗
Response,ca125_response,CA125反应,categorical,,Normalized,Decreased_50_Percent,Decreased_Less,Increased,,,N,正常化/下降≥50%/下降<50%/升高,GCIG标准
Response,recist_response,RECIST反应,categorical,,Complete_Response,Partial_Response,Stable_Disease,Progressive_Disease,,,N,完全缓解/部分缓解/疾病稳定/疾病进展,影像学评估
Adverse_Events,treatment_toxicity,治疗毒性,categorical,,Grade_1,Grade_2,Grade_3,Grade_4,,,N,1-4级,CTCAE分级
Adverse_Events,neurotoxicity,神经毒性,categorical,,None,Mild,Moderate,Severe,,,N,无/轻度/中度/重度,紫杉醇周围神经病变
Follow_Up,time_to_recurrence,复发时间,integer,months,0-200,,,N,治疗完成至复发,铂敏感性判定
Follow_Up,progression_free_survival,无进展生存期,integer,months,0-200,,,N,PFS,疗效指标
Follow_Up,overall_survival,总生存期,integer,months,0-200,,,N,OS,预后指标
Report,gynecologic_oncologist,妇科肿瘤医师,string,,,,,Y,主管医师,责任医师
Report,report_date,报告日期,date,,,,,Y,报告时间,文档记录
